Abbott Laboratories Stock Rises Monday, Still Underperforms Market

Dow Jones2022-08-16

DJ Abbott Laboratories Stock Rises Monday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories $(ABT)$ inched 0.38% higher to $111.90 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.40% to 4,297.14 and the Dow Jones Industrial Average rising 0.45% to 33,912.44. This was the stock's fourth consecutive day of gains. Abbott Laboratories closed $30.70 below its 52-week high ($142.60), which the company reached on December 27th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 0.48% to $166.09, Roche Holding AG Part. Cert. rose 3.96% to $336.40, and Pfizer Inc. $(PFE)$ fell 0.72% to $49.75. Trading volume (2.9 M) remained 1.7 million below its 50-day average volume of 4.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 15, 2022.

 

$(END)$ Dow Jones Newswires

August 15, 2022 16:33 ET (20:33 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment